At the same time, glucocorticoids decrease the function of the remaining osteoblasts directly and indirectly through the inhibition of insulin-like growth factor I expression [20]. Since most IBD patients are or have been on steroids at some point of the disease, this could be a confounding factor. Direct standardization was used to adjust for this confounder. This evidence concerns the gene IGF1 and irritable bowel syndrome.